ArticleCNS drugs2025

Safety and Efficacy of Deutetrabenazine at High versus Lower Daily Dosages in the ARC-HD Study to Treat Chorea in Huntington Disease.

Samuel Frank et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.